Subtype
Breast Atypical Lobular Hyperplasia
CI-CAN-00000593ALHExplore in graph →
Non-malignant2 active trials
- NCIt
- C4730
Loading cancer entity…
Subtype
CI-CAN-00000593ALHExplore in graph →
Clinical trials
11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02928978 | Ruxolitinib for Premalignant Breast Disease(TBCRC042) | completed | Phase 2 | 84 | Julie NangiaOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT03323658 | Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2023 | clinicaltrials |
| NCT00620087 | Molecular Breast Imaging in Women With Atypia and LCIS | completed | N/A | 66 | Mayo ClinicOTHER | 1 | Oct 10, 2016 | clinicaltrials |
| NCT01874184 | Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer |
Data updated 22 days agoSource updated Apr 13, 2026source: clinicaltrials
| completed |
| N/A |
| 17 |
| University of WashingtonOTHER |
| 1 |
| Jan 20, 2016 |
| clinicaltrials |